TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Aurena Laboratories Holding AB
Closing information (x1000 EUR)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
19,787
|
18,958
|
16,491 |
| Financial expenses |
148
|
92
|
62 |
| Earnings before taxes |
1,238
|
995
|
896 |
| EBITDA |
1,858
|
1,612
|
1,326 |
| Total assets |
17,737
|
16,733
|
15,062 |
| Current assets |
8,164
|
6,928
|
6,265 |
| Current liabilities |
4,791
|
3,145
|
2,800 |
| Equity capital |
9,355
|
9,311
|
8,811 |
| - share capital |
45
|
49
|
50 |
| Employees (average) |
76
|
76
|
74 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
52.7%
|
55.6%
|
58.5% |
| Turnover per employee |
260
|
249
|
223 |
| Profit as a percentage of turnover |
6.3%
|
5.2%
|
5.4% |
| Return on assets (ROA) |
7.8%
|
6.5%
|
6.4% |
| Current ratio |
170.4%
|
220.3%
|
223.8% |
| Return on equity (ROE) |
13.2%
|
10.7%
|
10.2% |
| Change turnover |
2,365
|
2,772
|
-4,834 |
| Change turnover % |
14%
|
17%
|
-23% |
| Chg. No. of employees |
0
|
2
|
1 |
| Chg. No. of employees % |
0%
|
3%
|
1% |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.